Drug manufacturer Boehringer Ingelheim is being sued by plaintiff B. Jean Tonioli amid claims that the company’s drug Dabigatran (brand name Pradaxa) caused the wrongful death of her husband when he started bleeding uncontrollably after taking the pills to treat his AF. The decedent’s family — Jason Tonioli, Kristin Brandenburg, Karen Wilson and Jennifer Tonioli Anderson — have also joined the lawsuit.
This lawsuit was filed on June 27, 2013 in the Second Judicial District Court in the State of Utah. On July 17, 2013, the defendants filed a notice of removal, requesting that the case be transferred instead to the federal court in the U.S. District Court for the District of Utah. The complaint states that Robert C. Tonioli started taking Pradaxa for his atrial fibrillation (AF) on March 4, 2011. During his vacation on June 26, 2011, Tonioli was sent to the hospital after suffering from stomach pains and convulsions. He was diagnosed with a bowel obstruction that caused internal bleeding. It is believed that Tonioli’s Pradaxa use caused his internal bleeding and prevented his being able to be treated for his bowel obstruction because of the Pradaxa’s tendency to cause even more unstoppable bleeding. Given blood infusions instead, Tonioli eventually died on June 27 from internal bleeding.
AF, in which patients experience a rapid or fluttering heartbeat, is treated with other anticoagulant medications like Multaq as well. Multaq is made by Sanofi-Aventis and has been linked to serious side effects including a worsening of the heart condition, liver failure and lung toxicity. It is for this reason that the FDA has recommended that doctors only prescribe Multaq if all other medications fail to work.
If you or a loved one has suffered from liver failure or a worsening heart condition after being treated with Multaq, contact the attorneys at Greg Jones today for a free consultation. I am experienced at fighting Multaq lawsuits and may be able to help you recover money for your injuries.